Healthcare provider profile · identity verified

Michael E Fath, D.O.

Family Practice · KINGSTON, PA · NPI 1487631214

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	504	118
Levothyroxine Sodium	Levothyroxine Sodium	497	89
Amlodipine Besylate	Amlodipine Besylate	482	108
Omeprazole	Omeprazole	358	71
Metoprolol Succinate	Metoprolol Succinate	232	46
Metformin Hcl	Metformin Hcl	204	49
Metoprolol Tartrate	Metoprolol Tartrate	184	35
Simvastatin	Simvastatin	184	47
Fluticasone Propionate	Fluticasone Propionate	182	72
Lisinopril	Lisinopril	182	38
Losartan Potassium	Losartan Potassium	175	41
Rosuvastatin Calcium	Rosuvastatin Calcium	171	41
Escitalopram Oxalate	Escitalopram Oxalate	148	31
Potassium Chloride	Potassium Chloride	147	31
Sertraline Hcl	Sertraline Hcl	142	26
Famotidine	Famotidine	134	29
Tamsulosin Hcl	Tamsulosin Hcl	133	25
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	127	33
Furosemide	Furosemide	124	33
Gabapentin	Gabapentin	124	21
Pantoprazole Sodium	Pantoprazole Sodium	124	28
Hydrochlorothiazide	Hydrochlorothiazide	122	29
Allopurinol	Allopurinol	115	25
Synthroid	Levothyroxine Sodium	93	17
Eliquis	Apixaban	92	15
Jardiance	Empagliflozin	86	14
Albuterol Sulfate Hfa	Albuterol Sulfate	82	28
Atenolol	Atenolol	80	19
Clopidogrel	Clopidogrel Bisulfate	80	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	75	16
Prednisone	Prednisone	74	49
Pravastatin Sodium	Pravastatin Sodium	67	19
Fenofibrate	Fenofibrate	64	suppressed
Glimepiride	Glimepiride	60	15
Warfarin Sodium	Warfarin Sodium	60	suppressed
Carvedilol	Carvedilol	50	13
Citalopram Hbr	Citalopram Hydrobromide	50	suppressed
Ezetimibe	Ezetimibe	48	suppressed
Trazodone Hcl	Trazodone Hcl	48	11
Alprazolam	Alprazolam	47	suppressed
Tramadol Hcl	Tramadol Hcl	45	suppressed
Finasteride	Finasteride	41	suppressed
Ozempic	Semaglutide	41	suppressed
Torsemide	Torsemide	41	suppressed
Lansoprazole	Lansoprazole	40	suppressed
Risedronate Sodium	Risedronate Sodium	40	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	39	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	38	suppressed
Metformin Hcl Er	Metformin Hcl	37	suppressed
Tradjenta	Linagliptin	37	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	37	suppressed
Montelukast Sodium	Montelukast Sodium	36	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	36	suppressed
Ropinirole Hcl	Ropinirole Hcl	35	suppressed
Azithromycin	Azithromycin	34	28
Mirtazapine	Mirtazapine	34	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	32	suppressed
Celecoxib	Celecoxib	31	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	31	25
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	30	29
Enalapril Maleate	Enalapril Maleate	29	suppressed
Digoxin	Digoxin	28	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	27	17
Alendronate Sodium	Alendronate Sodium	26	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	25	suppressed
Levofloxacin	Levofloxacin	25	21
Clonidine Hcl	Clonidine Hcl	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Armour Thyroid	Thyroid,pork	23	suppressed
Myrbetriq	Mirabegron	23	suppressed
Xarelto	Rivaroxaban	23	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	22	suppressed
Meloxicam	Meloxicam	22	suppressed
Modafinil	Modafinil	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	15
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Ondansetron Odt	Ondansetron	20	suppressed
Ramipril	Ramipril	20	suppressed
Breo Ellipta	Fluticasone/Vilanterol	19	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Glipizide Er	Glipizide	18	suppressed
Mounjaro	Tirzepatide	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	18
Januvia	Sitagliptin Phosphate	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Amoxicillin	Amoxicillin	16	12
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	16	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	16	suppressed
Nateglinide	Nateglinide	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	11
Carbamazepine	Carbamazepine	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Cefdinir	Cefdinir	13	11
Diazepam	Diazepam	13	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	13	12
Duloxetine Hcl	Duloxetine Hcl	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Nystatin	Nystatin	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Colchicine	Colchicine	12	suppressed
Diltiazem Hcl	Diltiazem Hcl	12	suppressed
Glyxambi	Empagliflozin/Linagliptin	12	suppressed
Klor-Con M15	Potassium Chloride	12	suppressed
Naproxen	Naproxen	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	12	suppressed
Bethanechol Chloride	Bethanechol Chloride	11	suppressed
Dexilant	Dexlansoprazole	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error